| Net Cash Provided by (Used in) Operating Activities |
$3,938,839 |
USD |
61% |
Q1 2025 |
Q1 2025 |
| Net Cash Provided by (Used in) Financing Activities |
$41,135,217 |
USD |
|
Q1 2025 |
Q1 2025 |
| Net Cash Provided by (Used in) Investing Activities |
$0 |
USD |
|
Q1 2025 |
Q1 2025 |
| Common Stock, Shares Authorized |
300,000,000 |
shares |
0% |
Q3 2025 |
Q3 2025 |
| Common Stock, Shares, Issued |
95,570,483 |
shares |
10% |
Q4 2024 |
FY 2024 |
| Common Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Q3 2025 |
Q3 2025 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
$33,022,053 |
USD |
125% |
Q3 2025 |
Q3 2025 |
| Deferred Tax Assets, Valuation Allowance |
$16,866,137 |
USD |
64% |
Q4 2024 |
FY 2024 |
| Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent |
0.21 |
pure |
0% |
Q3 2025 |
Q3 2025 |
| Deferred Tax Assets, Gross |
$16,866,137 |
USD |
51% |
Q4 2024 |
FY 2024 |
| Depreciation |
$235,602 |
USD |
-24% |
Q1 2025 |
Q1 2025 |
| Payments to Acquire Property, Plant, and Equipment |
$0 |
USD |
-100% |
Q1 2025 |
Q1 2025 |
| Property, Plant and Equipment, Gross |
$3,191,418 |
USD |
8.4% |
Q3 2025 |
Q3 2025 |
| Operating Lease, Liability, Current |
$129,419 |
USD |
-4.2% |
Q4 2024 |
FY 2024 |
| Operating Lease, Weighted Average Discount Rate, Percent |
0.12 |
pure |
0% |
Q3 2025 |
Q3 2025 |
| Deferred Income Tax Expense (Benefit) |
$0 |
USD |
|
Q1 2025 |
Q1 2025 |
| Lessee, Operating Lease, Liability, Undiscounted Excess Amount |
$290,000 |
USD |
71% |
Q3 2025 |
Q3 2025 |
| Deferred Tax Assets, Operating Loss Carryforwards |
$10,066,561 |
USD |
21% |
Q4 2024 |
FY 2024 |
| Current Income Tax Expense (Benefit) |
$44,084 |
USD |
|
Q2 2024 |
Q2 2024 |
| Additional Paid in Capital |
$213,101,173 |
USD |
30% |
Q3 2025 |
Q3 2025 |
| Deferred Tax Assets, Net of Valuation Allowance |
$0 |
USD |
-100% |
Q4 2024 |
FY 2024 |
| Interest Expense |
$1,289 |
USD |
-100% |
Q3 2025 |
Q3 2025 |